Nurix Therapeutics, Inc.
2020 Q3 - 2025 Q4 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 1,290 | 0.0% | 68,019 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 615 | 0.0% | 66,543 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 763 | 0.0% | 66,994 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 796 | 0.0% | 66,994 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 986 | 0.0% | 52,331 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 1,179 | 0.0% | 52,454 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 1,043 | 0.0% | 49,974 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 70 | 0.0% | 4,786 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 81 | 0.0% | 7,835 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 350 | 0.0% | 44,585 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 510 | 0.0% | 51,061 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 429 | 0.0% | 48,315 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 540 | 0.0% | 49,161 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 617 | 0.0% | 47,323 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 599 | 0.0% | 47,246 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 426 | 0.0% | 30,372 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 978 | 0.0% | 33,799 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 998 | 0.0% | 33,312 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 1,146 | 0.0% | 43,188 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 1,123 | 0.0% | 36,111 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 579 | 0.0% | 17,620 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 587 | 0.0% | 16,805 | 9/30/2020 |